FDA Orange Book · active-ingredient family
Iron sucrose
Iron sucrose is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:VENOFER · NDA 021135
1
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
3
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| VENOFERRLD×5 | AM REGENT | NDA 021135 | AB | Mar 20, 2005 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| IRON SUCROSE×3 | INTL MEDICATION SYS | ANDA 208977 | AB | Aug 08, 2025 | |
| IRON SUCROSE×3 | MYLAN LABS LTD | ANDA 212559 | AB | Aug 08, 2025 | |
| IRON SUCROSE×3 | SANDOZ | ANDA 212340 | AB | Aug 08, 2025 |
Marketing exclusivity (3)
- CGTFDA marketing exclusivity
Feb 08, 2026
4 mo ago
- CGTFDA marketing exclusivity
Feb 07, 2026
4 mo ago
- CGTFDA marketing exclusivity
Feb 07, 2026
4 mo ago
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Iron sucrose — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

